DK2527842T3 - Neuropeptidfrisætningsanalyse til natriumkanaler - Google Patents

Neuropeptidfrisætningsanalyse til natriumkanaler

Info

Publication number
DK2527842T3
DK2527842T3 DK12167014.5T DK12167014T DK2527842T3 DK 2527842 T3 DK2527842 T3 DK 2527842T3 DK 12167014 T DK12167014 T DK 12167014T DK 2527842 T3 DK2527842 T3 DK 2527842T3
Authority
DK
Denmark
Prior art keywords
sodium channels
release analysis
neuropeptide release
neuropeptide
analysis
Prior art date
Application number
DK12167014.5T
Other languages
English (en)
Inventor
Haber Nicole M Alessandri
Lynn Macdonald
Michael L Lacroix-Fralish
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/155,491 external-priority patent/US8871996B2/en
Priority claimed from US13/236,117 external-priority patent/US8486647B2/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of DK2527842T3 publication Critical patent/DK2527842T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK12167014.5T 2011-05-12 2012-05-07 Neuropeptidfrisætningsanalyse til natriumkanaler DK2527842T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161485488P 2011-05-12 2011-05-12
US13/155,491 US8871996B2 (en) 2010-06-09 2011-06-08 Mice expressing human voltage-gated sodium channels
US13/236,117 US8486647B2 (en) 2010-06-09 2011-09-19 Neuropeptide release assay for sodium channels

Publications (1)

Publication Number Publication Date
DK2527842T3 true DK2527842T3 (da) 2013-09-08

Family

ID=46045997

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12167014.5T DK2527842T3 (da) 2011-05-12 2012-05-07 Neuropeptidfrisætningsanalyse til natriumkanaler
DK13169122.2T DK2631654T3 (da) 2011-05-12 2012-05-07 Neuropeptidfrigivelsesassay til natriumkanaler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13169122.2T DK2631654T3 (da) 2011-05-12 2012-05-07 Neuropeptidfrigivelsesassay til natriumkanaler

Country Status (7)

Country Link
EP (3) EP2579039B1 (da)
CY (1) CY1116625T1 (da)
DK (2) DK2527842T3 (da)
ES (2) ES2541535T3 (da)
HK (2) HK1174387A1 (da)
PL (1) PL2631654T3 (da)
PT (1) PT2631654E (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150127618A (ko) 2013-03-14 2015-11-17 리제너론 파아마슈티컬스, 인크. Nav1.7에 대한 사람 항체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
EP2767161B1 (en) 2004-10-19 2018-02-07 Regeneron Pharmaceuticals, Inc. Method for generating an non-human animal homozygous for a genetic modification
US20090298095A1 (en) 2005-04-15 2009-12-03 The John Hopkins University Immortalization of cells including neuronal cells
WO2007109324A2 (en) * 2006-03-21 2007-09-27 Xenon Pharmaceuticals, Inc. Potent and selective nav 1.7 sodium channel blockers
US7582298B2 (en) 2006-06-02 2009-09-01 Regeneron Pharmaceuticals, Inc. High affinity antibodies to human IL-6 receptor
TWI476280B (zh) 2008-03-07 2015-03-11 Regeneron Pharma 來自二倍體宿主胚胎注射之es-細胞衍生的老鼠
US20110312533A1 (en) * 2009-02-02 2011-12-22 Chromocell Corporation CELL LINES EXPRESSING NaV AND METHODS OF USING THEM

Also Published As

Publication number Publication date
ES2541535T3 (es) 2015-07-21
EP2579039B1 (en) 2017-10-25
HK1174387A1 (en) 2013-06-07
PL2631654T3 (pl) 2015-09-30
ES2656852T3 (es) 2018-02-28
DK2631654T3 (da) 2015-07-20
EP2631654A1 (en) 2013-08-28
EP2631654B1 (en) 2015-04-15
EP2527842A1 (en) 2012-11-28
EP2579039A1 (en) 2013-04-10
EP2527842B1 (en) 2013-06-05
PT2631654E (pt) 2015-08-21
HK1185943A1 (en) 2014-02-28
CY1116625T1 (el) 2017-03-15

Similar Documents

Publication Publication Date Title
DK2751387T3 (da) Selvsuspenderende proppanter til hydraulisk frakturering
DK3829176T3 (da) Fremgangsmåde til at konstruere fletningsliste
CO6940421A2 (es) Inhibidores de neprilisina
CO6781518A2 (es) Inhibidores de neprilisina
DK2783152T3 (da) Trykafgivelsessystem
BR112014012016A2 (pt) compostos
DK2564396T3 (da) Fremgangsmåde til isotop-fremstilling
DK2672973T3 (da) Indgivelsesplan til nitrocatecholer
DK2787982T3 (da) Sammensætning til tarmpræparat
DE112012003251A5 (de) Ausrücksystem
FI20115703A (fi) Näytteenotin
DE112012003262A5 (de) Ausrücksystem
DK2768442T3 (da) Fastgørelsesmekanisme til stomiposer
DK2505772T3 (da) Hydraulisk indretning
DK2788353T3 (da) Bur-aminligander til metallo-radiofarmaceutika
DK2572579T3 (da) Sammensætninger til at tiltrække tortricidae (viklere)
DE112012003257A5 (de) Ausrücksystem
CO6920305A2 (es) Heterociclilpiri(mi)dinilpirazol
DK2522421T3 (da) Fremgangsmåde til opnåelse af mikrokapsler
DK2745928T3 (da) Fremgangsmåde til emulsionsfremstilling
BR112013022508A2 (pt) novos compostos de azaespirodecanona
CO6920302A2 (es) Heterociclilpir(mi)dinilpirazoles
DE112012002820A5 (de) Hebelsystem
DK2731630T3 (da) Autoklav til medicinsk-dental anvendelse
DK2527842T3 (da) Neuropeptidfrisætningsanalyse til natriumkanaler